Description
Follistatin-344 1 mg Genheal — Manufactured to exacting pharmaceutical standards, designed for targeted physiological enhancement. Manufactured under strict quality standards. This formulation is dosed at 1 mg per unit.
Key Benefits
- Myostatin-binding protein — inhibits myostatin-driven muscle-growth ceiling
- Research interest in muscle-wasting and sarcopenia reversal
- SubQ dosing, short pulse courses
- No HPTA impact; no PCT required
- Synergistic with resistance training protocols
- Each unit dosed at 1 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 100 mcg/day SubQ for 10 days, typically 2–3 cycles per year. Higher-dose protocols (300 mcg/day) exist in research literature.
How It Works
Endogenous protein that binds and neutralises myostatin and related TGF-β superfamily members (activin, GDF-11). Myostatin is a negative regulator of muscle growth — inhibiting it uncaps the hypertrophy ceiling. Research compound with limited human safety data.
Pharmacokinetics
Plasma half-life approximately 30 hours for follistatin-344 variant. Daily dosing with pulse protocols. Reconstituted fridge-stable 4–6 weeks.
Potential Side Effects
Research-grade compound with limited safety data in humans. Short pulse protocols preferred. No documented HPTA impact.
Cycle & Stacking Guide
10-day pulses, 2–3× yearly. Paired with resistance training during the pulse for maximal hypertrophy effect. Stackable with standard AAS cycles.
Manufacturer Notes
Genheal specialises in HGH, peptides, and research compounds. Lyophilised products ship with standard cold-chain documentation.
Storage & Handling
Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.
Reviews
There are no reviews yet.